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Subacute endotoxemia induces adipose inflammation and
changes in lipid and lipoprotein metabolism in cats
Abstract
Acute inflammation in humans is associated with transient insulin resistance (IR) and dyslipidemia.
Chronic low-grade inflammation is a pathogenic component of IR and adipose tissue dysfunction in
obesity-induced type 2 diabetes. Because feline diabetes closely resembles human type 2 diabetes, we
studied whether lipopolysaccharide (LPS)-induced subacute inflammation, in the absence of obesity, is
the potential primary cause of IR and metabolic disorders. Cats received increasing iv doses (10-1000
ng/kg(-1) · h(-1)) of LPS (n = 5) or saline (n = 5) for 10 d. Body temperature, proinflammatory and
metabolic markers, and insulin sensitivity were measured daily. Tissue mRNA and protein expression
were quantified on d 10. LPS infusion increased circulating and tissue markers of inflammation. Based
on the homeostasis model assessment, endotoxemia induced transient IR and β-cell dysfunction. At the
whole-body level, IR reverted after the 10-d treatment; however, tissue-specific indications of IR were
observed, such as down-regulation of adipose glucose transporter 4, hepatic peroxisome proliferative
activated receptor-γ1 and -2, and muscle insulin receptor substrate-1. In adipose tissue, increased
hormone-sensitive lipase activity led to reduced adipocyte size, concomitant with increased plasma and
hepatic triglyceride content and decreased total and high-density lipoprotein cholesterol levels.
Prolonged LPS-induced inflammation caused acute IR, followed by long-lasting tissue-specific
dysfunctions of lipid-, glucose-, and insulin metabolism-related targets; this ultimately resulted in
dyslipidemia but not whole-body IR. Endotoxemia in cats may provide a promising model to study the
cross talk between metabolic and inflammatory responses in the development of adipose tissue
dysfunction and IR.
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Abstract 
Acute inflammation in humans is associated with transient insulin resistance (IR) and 
dyslipidemia. Chronic low-grade inflammation is a pathogenic component of IR and adipose 
tissue dysfunction in obesity-induced type 2 diabetes. Because feline diabetes closely 
resembles human type 2 diabetes, we studied whether lipopolysaccharide (LPS)-induced 
subacute inflammation, in the absence of obesity, is the potential primary cause of IR and 
metabolic disorders. Cats received increasing iv doses (10–1000 ng/kg−1 · h−1) of LPS (n = 5) 
or saline (n = 5) for 10 d. Body temperature, proinflammatory and metabolic markers, and 
insulin sensitivity were measured daily. Tissue mRNA and protein expression were quantified 
on d 10. LPS infusion increased circulating and tissue markers of inflammation. Based on the 
homeostasis model assessment, endotoxemia induced transient IR and β-cell dysfunction. At 
the whole-body level, IR reverted after the 10-d treatment; however, tissue-specific 
indications of IR were observed, such as down-regulation of adipose glucose transporter 4, 
hepatic peroxisome proliferative activated receptor-γ1 and -2, and muscle insulin receptor 
substrate-1. In adipose tissue, increased hormone-sensitive lipase activity led to reduced 
adipocyte size, concomitant with increased plasma and hepatic triglyceride content and 
decreased total and high-density lipoprotein cholesterol levels. Prolonged LPS-induced 
inflammation caused acute IR, followed by long-lasting tissue-specific dysfunctions of lipid-, 
glucose-, and insulin metabolism-related targets; this ultimately resulted in dyslipidemia but 
not whole-body IR. Endotoxemia in cats may provide a promising model to study the cross 
talk between metabolic and inflammatory responses in the development of adipose tissue 
dysfunction and IR.  
In recent years, chronic activation of the innate and adaptive immune system has been 
causally linked to the development of insulin resistance (IR) in metabolic diseases such as 
diet-induced obesity and type 2 diabetes (1, 2). In mice, infiltration of adipose tissue by 
neutrophils and macrophages and activation of toll-like receptors (TLRs), e.g. TLR4, in these 
cells induce a local release of inflammatory cytokines (3,–,5). The activation of inflammatory 
cascades is believed to increase the activity of serine/threonine kinases and to promote 
phosphorylation of insulin receptor substrate (IRS) sites, which results in impaired insulin 
receptor signaling and defective insulin-mediated glucose metabolism (6, 7). Interestingly, 
excess circulating nonesterified fatty acids (NEFAs) and triglycerides (TGs), which may be 
derived from increased lipolytic activity in adipose tissue, also block insulin action through 
direct or cytokine-mediated activation of serine kinases. Indeed, saturated NEFAs can elicit 
TLR4-dependent synthesis of cytokines in murine adipose cells and macrophages (8, 9). As a 
consequence, the low-grade chronic increase of cytokines and chemokines and the increased 
circulating levels of TGs and NEFAs gradually impair insulin sensitivity in obesity.  
Infection and inflammation lead to changes in lipid and lipoprotein profile comparable with 
those observed in obesity and type 2 diabetes. High-plasma TG levels or 
hypercholesterolemia combined with low levels of high-density lipoprotein (HDL) 
cholesterol are typical features of dyslipidemia and contribute to IR in the human metabolic 
syndrome.  
The activation of a chronic inflammatory state may not only be the primary cause of obesity-
induced IR, but any disease involving inflammation may also eventually be linked to IR and 
alterations in lipid and lipoprotein metabolism. This hypothesis is supported by clinical and 
experimental evidence showing that glucose intolerance, IR, and dyslipidemia naturally 
develop during acute infection and critical illness in humans (10). However, whether 
inflammation is sufficient as the key initiating event in the development of IR and 
abnormalities in lipid or glucose metabolism in the absence of obesity or whether it is a 
secondary event to obesity-related disorders remains to be determined. Especially, the role of 
tissue-specific inflammation, e.g. in adipose tissue, in the impairment of insulin signaling 
pathways during infection or critical illness needs to be addressed.  
Experimental endotoxemia has been widely used as model of bacterial infection, 
inflammation, and sepsis and was shown to change glucose and lipid metabolism in a way 
that resembles that observed in humans with the metabolic syndrome (10,–,12). In most 
studies, however, bacterial lipopolysaccharide (LPS) has been administered at high doses for 
no longer than a few hours (13), mimicking more an acute-phase response than a subacute or 
chronic inflammatory condition. Only a single study has been published indicating that 
chronic endotoxemia may be sufficient to induce IR and obesity in mice (14). However, 
deeper insights into the regulatory mechanisms of insulin, glucose, and lipid metabolism 
during prolonged LPS exposure in humans or in animal models which spontaneously develop 
type 2 diabetes are needed.  
In contrast to current rodent models, cats naturally develop a form of diabetes that shares 
many similarities to human type 2 diabetes, including obesity-induced IR and dyslipidemia, 
impaired β-cell function and pancreatic amyloid deposition (15, 16). Recently we have shown 
that sustained hyperglycemia and hyperlipidemia promotes inflammatory responses in 
experimental cats and led to increased circulating and tissue levels of inflammatory markers 
(17, 18). In addition, some studies reviewed by Rand et al. (19) suggested that IR may be 
ameliorated in diabetic cats if concurrent inflammatory diseases are successfully treated.  
In the present study, we investigated whether, in the absence of obesity, a 10-d infusion of 
LPS in cats induces a low-grade inflammatory response similar to that in humans with the 
metabolic syndrome. We hypothesized that continuous exposure to small doses of LPS in 
cats, besides activating inflammation and impairing insulin sensitivity, has a detrimental 
effect on tissue-specific genes linked to glucose and lipid metabolism.  
 
Materials and Methods 
Ten neutered male, 12- to 15-month-old healthy domestic shorthair cats (Liberty Research, 
Waverly, NY) were used. All cats were healthy based on clinical examination and 
hematological and serum biochemical analyses. During the study cats were housed 
individually in single cages. The experiment was approved by the Veterinary Office, Zurich, 
Switzerland (no. 116/2007).  
The experimental paradigm is shown in Fig. 1. Animals were adapted to housing and feeding 
conditions for 5 wk before the baseline iv glucose tolerance test (ivGTT) was performed as 
described (17). After a 2-wk recovery period, animals were randomly allocated to two groups 
(n = 5 each) to receive either increasing doses of iv LPS or saline infusion. Groups were 
matched based on their glucose half-life during the baseline ivGTT and based on body weight 
at the end of the recovery period (d 0). On d 0, a jugular catheter was implanted and a 
telemetric transmitter (Data Sciences International, St. Paul, MN; see Supplemental Materials 
and Methods, published on The Endocrine Society's Journals Online web site at 
http://endo.endojournals.org) to record body temperature was placed sc on the back of the 
cats' neck under general anesthesia, as described (17). Infusion of increasing doses of LPS 
derived from Escherichia coli 0127:B8 [10 (0–6 h), 200 (7–24 h), 500 (25–140 h), and 1000 
(141–240 h) ng/kg−1 · −1 diluted in saline and infused at 2–4 ml/kg−1 · h−1; Sigma-Aldrich, St. 
Louis, MO] or saline (2 ml/kg−1 · h−1) was started after complete recovery from anesthesia 
and was maintained for 10 d. LPS doses had been previously determined in a pilot study 
(Supplemental Fig. 1). During the pilot study, the LPS concentration of the solution and the 
infusion rate were gradually increased to raise and maintain rectal temperature just above 
normal range for cats, i.e. to targeted levels between 39.2 and 40.5 C. During the 10-d 
infusion, daily blood samples (0.5 ml) were collected after overnight fasting for biochemical 
analysis. A second ivGTT was performed 1 h after the end of the infusion. Thereafter cats 
were euthanized and tissue biopsies were excised, as described (17).  
 
 
 
Fig. 1.  
Overview of the study design. Animals were adapted to the housing and feeding conditions 
for 5 wk before a baseline ivGTT was performed. After a recovery period of at least 2 wk, a 
catheter was implanted in the jugular vein and a telemetric transmitter was placed sc under 
general anesthesia (d 0). Animals were randomly divided into two groups of five cats each to 
receive either increasing doses of LPS (10, 200, 500, and 1000 ng/kg−1 · h−1) or saline. During 
the 10-d infusion, daily blood samples (0.5 ml) were collected after overnight fasting for 
biochemical analysis. On d 10, a second ivGTT was performed 1 h after the end of the 
infusion. At the end of the second ivGTT, tissue biopsies were excised.  
 
Biochemical analysis and assessment of insulin sensitivity and β-cell function 
Daily fasting values of glucose, insulin, TGs, NEFAs, and α1-acid glycoprotein (AGP) were 
measured as described elsewhere (17). Plasma lipoproteins and characterization of lipoproteic 
fractions were performed on d 10 as outlined in Supplemental Materials and Methods 
(Diagnostic Service, University of Bristol, Langford, Bristol, UK). Serum cortisol was 
measured on d 0, 1, and 10 by a competitive chemiluminescent immunoassay (Bayer, 
Tarrytown, NY). On d 10, plasma monocyte-chemotactic protein-1 (MCP-1) and serum 
amyloid A (SAA) and liver TGs were assessed as outlined in Supplemental Materials and 
Methods.  
Fasting glucose and insulin values were used to calculate daily baseline insulin sensitivity and 
β-cell function with the homeostasis model assessment (HOMA-IR and HOMA-B, 
respectively) (20,–,22). The ivGTTs were performed to estimate insulin sensitivity, which 
was calculated with the whole-body insulin sensitivity index as described by Matsuda and 
DeFronzo (23) and to estimate β-cell function by using the insulin secretion index (24).  
 
Tissue samples 
Tissue biopsies from pancreas, liver, skeletal muscle, and visceral and subcutaneous fat were 
collected immediately after the second ivGTT as described (17). One aliquot of each tissue 
was fixed in 10% buffered formalin for 24 h and embedded. One aliquot was embedded in 
Tissue-Tek O.C.T. (optimal cutting temperature) compound (Leica Microsystems, Nussloch, 
Germany), and one additional aliquot of each tissue was immediately frozen in liquid nitrogen 
and stored at −80 C (see Supplemental Materials and Methods).  
 
Laser capture microdissection (LCM) of pancreatic islets, pancreatic islet clusters, RNA 
isolation, and real-time PCR 
Pancreatic islets were isolated with two methods. First, pancreatic islet-like clusters (ILCs) 
were isolated as described (25, 26), RNA was isolated and cDNA was subjected to 
quantitative real-time PCR for the macrophage marker F4/80, for MCP-1 and for IL-8. The 
second method of pancreatic islet isolation consists of microdissecting islets with the LCM 
technique; RNA was isolated and cDNA was subjected to quantitative real-time PCR for 
insulin, IL-6, and IL-8 (see Supplemental Materials and Methods).  
From insulin-sensitive tissues (liver, skeletal muscle, and visceral and sc fat), RNA was 
extracted and cDNA was obtained according to standard protocols (27). Quantitative real-
time PCR was performed for adiponectin, resistin, glucose transporter (GLUT)-1, GLUT4, 
peroxisome proliferative activated receptor (PPAR)-γ1, PPARγ2, insulin receptor, IRS-1, 
MCP-1, neutrophil elastase (NEla), the macrophage-specific antigen F4/80, TLR-4, IL-8, IL-
1β, IL-6, TNF-α, hormone-sensitive lipase (HSL), suppressor of cytokine signaling (SOCS)-
3, and perilipin (see Supplemental Materials and Methods). cDNA samples were run in 
triplicate, and transcripts were quantified using the relative standard curve method. A 
template-free control and a sample without reverse transcriptase were included in each 
amplification run. Gene expression was normalized to the respective quantities of 
glyceraldehyde-3-phosphate dehydrogenase.  
 
Western blotting 
Whole liver and sc and visceral fat were homogenized in lysis buffer to obtain nuclear 
protein, enriched plasma membrane protein, or whole-cell protein lysates (see Supplemental 
Materials and Methods). Nuclear protein lysates were used for Western blot analysis of 
PPARγ; and enriched plasma membrane protein lysates for analysis of GLUT4; whole-cell 
protein lysate for analysis of total and phosphorylated HSL. Nuclear protein, enriched plasma 
membrane protein and whole-cell protein lysates (35, 20, and 50 µg, respectively) were run 
on a 10% sodium dodecyl sulfate-polyacrylamide gel, membranes were incubated overnight 
at 4 C with the following antibodies: PPARγ (E-8; Santa Cruz Biotechnology, Santa Cruz, 
CA), primary antisera to GLUT4 (kindly supplied by Dr. L. Reagan) (28), and GLUT4 
(GT41-S; α Diagnostic, San Antonio, TX), HSL, and phospho-HSL (Ser660) (4107 and 4126; 
Cell Signaling Technology, Danvers, MA). Western blotting was quantified by densitometry 
using β-actin as a loading control. Densitometric analysis was performed using Quantity One 
software (Bio-Rad Laboratories, Hercules, CA).  
 
Histopathology and immunohistochemistry 
Paraffin sections (3 µm) from all tissues tested were stained with hematoxylin and eosin for 
histomorphometry and with myeloperoxidase to count neutrophils as described (17). 
Adipocyte cross-sectional size was measured with ImageJ software 
(http://rsb.info.nih.gov/ij/). Average cell size was measured on five pictures collected from 
each cat's visceral and sc fat tissue at ×40 magnification; all adipocytes in one microscopic 
field were included in the analysis. Neutrophils in islets or exocrine pancreas sections were 
counted in 50 microscopic fields at ×40 magnification, excluding neutrophils in large blood 
vessels and interlobular tissue. The number of neutrophils was similarly counted as in 
samples collected from the other insulin-responsive tissues tested. Histological sections were 
evaluated in a blinded manner.  
 
HSL activity assay 
Visceral and sc fat (0.5 g) was homogenized in a homogenization buffer, and the fat-free 
infranatant (cytosolic-fraction) was collected and used for HSL activity assays as described 
elsewhere (29). Briefly, the cytosolic fraction (0.2 ml) was incubated with assay buffer 
containing a final concentration of 330 µm triolein and [3H] triolein. The reaction was 
terminated by adding 3.25 ml of extraction buffer and 1.05 ml of a 0.1 m potassium 
carbonate, and 0.1 m boric acid solution. After vortexing and centrifugation (800 × g, 15 
min), radioactivity was determined in 1 ml of the upper phase by liquid scintillation counting.  
Statistical analysis 
Data are expressed as mean ± se. Group differences were compared using the Mann-Whitney 
test. Data were analyzed using GraphPad Prism 4.0 (GraphPad, San Diego, CA). Significance 
was set at P < 0.05.  
 
Results 
Is a LPS-induced subacute endotoxemia sufficient to induce systemic inflammation in 
cats? 
Based on daily physical examinations and routine blood work, LPS infusion was well 
tolerated in cats. The mean body weight did not differ between baseline and after 10 d of the 
LPS or saline infusion (data not shown). Subcutaneous temperature progressively increased 
during LPS and significantly differed from controls from 15 to 121 h after the onset of 
infusion; afterward temperature gradually decreased to preinfusion values (Fig. 2A). LPS 
induced a rapid and marked increase in circulating AGP, which lasted throughout the infusion 
(Fig. 2B). On d 10, LPS-infused cats had elevated circulating levels of MCP-1 (99.5 ± 15.2 
saline vs. 260.7 ± 55.7 LPS; P < 0.01) and SAA (24.4 ± 21.2 saline vs. 158.7 ± 86.2 LPS; P < 
0.01) compared with controls (Fig. 2, C and D). These findings confirmed our hypothesis that 
the infusion of LPS in normal-weight cats is associated with a systemic inflammation that 
resembles, to some extent, the inflammatory states of obesity and type 2 diabetes in human 
patients.  
 
 
Fig. 2.  
Subacute endotoxemia induces systemic and tissue inflammation in cats. A, Mean change in 
sc body temperature after LPS (n = 5; filled circle) and saline (n = 5; open circle) infusion. 
Subcutaneous temperature was assessed every 2 h throughout the infusion period by 
telemetry. B, Circulating concentration of α1-acid glycoprotein during the 10-d infusion of 
LPS or saline. Values are expressed as mean ± se. C and D, Circulating concentration of 
MCP-1 (C) and SAA (D) of LPS- and saline-infused cats on d 10. E, Number of neutrophils 
relative to high-power field in visceral and sc adipose tissue, skeletal muscle, and liver of 
LPS- and saline-infused cats. Individual and mean values are shown; representative 
myeloperoxidase liver stainings are shown. Arrows show positively stained neutrophils. F, 
Relative quantities of F4/80 mRNA in pancreatic ILCs. The values are expressed as mean ± 
se and are relative to one cat infused with saline. *, P < 0.05 and †, P < 0.01 vs. saline-infused 
cats.  
 
Is a LPS-induced subacute endotoxemia sufficient to enhance expression of 
inflammation- and immune response-related genes particularly in sc fat?  
After 10 d of infusion, the number of neutrophils was increased in paraffin-embedded tissues 
of LPS-infused cats (visceral fat: 0.04 ± 0.01 vs. 0.08 ± 0.01; P = 0.09; sc fat: 0.06 ± 0.01 vs. 
0.11 ± 0.01; P < 0.05; skeletal muscle: 0.04 ± 0.01 vs. 0.07 ± 0.01; P < 0.05; liver: 20.2 ± 3.4 
vs. 33.0 ± 2.5 neutrophils per high power field; P < 0.05; saline- vs. LPS-infused cats; Fig. 
2E) except in islets and exocrine pancreas (data not shown). Transcripts of MCP-1, NEla, and 
IL-1β were increased in sc fat in the LPS group. Transcripts of the macrophage marker F4/80 
were augmented in pancreatic ILCs (0.5 ± 0.2 saline vs. 1.9 ± 0.5 LPS; P < 0.05; Fig. 2F) and 
in all insulin-sensitive tissues tested, except visceral fat. TLR-4 mRNA was reduced in 
skeletal muscle. In parallel, liver mRNA of IL-8 was increased (Table 1). These data clearly 
confirmed our hypothesis that the LPS-induced increase in circulating levels of inflammatory 
markers is paralleled by the tissue-specific activation of tissue markers of inflammation in the 
insulin-sensitive tissues tested and particularly in sc fat.  
 
 
Table 1.  
Inflammation- and insulin sensitivity-related genes in visceral and sc fat, skeletal muscle, and 
liver 
 
Is a LPS-induced subacute endotoxemia sufficient to induce transient IR and β-cell 
dysfunction? 
Fasting plasma glucose significantly increased, during the first 5 d of LPS infusion; glucose 
then progressively decreased back to baseline by d 7 (Fig. 3A). Plasma insulin concentration 
did not differ between groups (Fig. 3B). IR, as assessed by HOMA-IR, was significantly 
increased in the LPS group on d 2 and 3 and showed a trend toward an increase on d 4 (P = 
0.09 vs. saline) and 5 (P = 0.055 vs. saline); β-cell function based on HOMA-B was 
significantly decreased in the LPS cats on d 1 and 4 (Table 2). After 10 d of infusion, iv 
glucose tolerance as well as insulin secretion did not differ between LPS- and saline-infused 
cats (Fig. 3, C and D). Insulin mRNA expression was up-regulated by LPS compared with 
saline in islets excised by LCM (P = 0.057; Supplemental Fig. 2).  
 
Fig. 3.  
Subacute endotoxemia induces transient IR and β-cell dysfunction. A and B, Fasting plasma 
glucose (A) and insulin (B) levels during the 10-d LPS or saline infusion period in cats. C and 
D. Glucose (C) and insulin (D) levels during the final ivGTT in LPS- and saline-infused cats. 
Graphs E and F show the area under the curve (AUC) of glucose and insulin, respectively. 
Values are expressed as mean ± se. *, P < 0.05 vs. saline-infused cats.  
 
 
Table 2.  
Insulin sensitivity and β-cell function calculated with the homeostasis model assessment 
indices (HOMA-IR and HOMA-B, respectively) 
 
Is a LPS-induced subacute endotoxemia sufficient to modulate expression of insulin 
sensitivity-related genes in a tissue-specific manner in the insulin-sensitive tissues 
tested?  
LPS-infused animals had decreased mRNA levels of GLUT4 in visceral fat and increased 
transcript levels of SOCS3 in sc fat. IRS-1 expression was reduced and SOCS3 was 
augmented in skeletal muscle. LPS significantly decreased PPARγ1 and -2 levels in liver 
(Table 1). Protein levels of GLUT4 were lower in visceral fat after LPS (P = 0.056; data not 
shown); total PPARγ was significantly decreased in liver (Fig. 4A). These data confirmed our 
hypothesis that 10 d of LPS down-regulate the expression of important insulin signaling-
related targets in a tissue-specific manner and point toward the development of tissue-specific 
reduction in insulin sensitivity.  
 
 
Fig. 4.  
Subacute endotoxemia modulates expression of PPARγ in liver and alters lipid metabolism in 
cats. A, Protein content of total PPARγ in liver extracts of LPS- and saline-infused cats. B, A 
representative Western blots is shown. Results are normalized to β-actin. Values are 
expressed as mean ± se. C and D, Fasting plasma cortisol (C) and TG (D) levels during the 
10-d LPS or saline infusion in cats. Cortisol levels were measured daily in pooled plasma 
samples from the two treatment groups and only on d 0, 1, and 10 in individual cat plasma 
samples. Values are expressed as mean ± se. E and F, Average cross-sectional area of 
adipocytes in visceral (E) and sc fat (F) of LPS- and saline-infused cats. Individual and mean 
values are shown. Values are expressed relative to one cat infused with saline. *, P < 0.05 vs. 
saline-infused cats. G and H, Representative hematoxylin and eosin visceral (G) and sc (H) 
adipose tissue staining in cats after LPS or saline infusion.  
 
Is a LPS-induced subacute endotoxemia sufficient to alter lipid and lipoprotein 
metabolism in cats? 
In response to LPS, plasma TGs and cortisol sharply increased during the first 24 h and then 
rapidly decreased to baseline levels already by d 2 (Fig. 4, C and D). Fasting NEFA 
concentrations did not differ from controls at any time (data not shown). After 10 d LPS 
infusion, the average cross-sectional size of both visceral and sc adipocytes was significantly 
reduced by 33 and 37%, respectively, compared with saline (visceral fat: 0.9 ± 0.1 vs. 0.6 ± 
0.1; P < 0.05; sc fat: 0.8 ± 0.1 vs. 0.5 ± 0.04 adipocyte size normalized to one cat; P < 0.05, 
saline- vs. LPS-infused cats; Fig. 4, E–H). Decreased mRNA expression of perilipin in both 
adipose fat tissues (Fig. 5A) was accompanied by a 50% increase in HSL activity in sc 
adipose tissue extracts from the LPS cats (Fig. 5B). Western blot analysis confirmed an 
enhanced expression of total HSL in visceral adipose tissue (Fig. 5C) and of total and 
phosphorylated HSL protein in sc adipose tissue (Fig. 5D). The content of TGs in liver was 
increased by 24% compared with the saline-infused cats (25.6 ± 0.9 saline vs. 31.8 ± 0.4 mg/g 
LPS; P < 0.05; Fig. 5E). Furthermore, plasma concentration of phospholipids and total and 
esterified cholesterol were significantly lower in the LPS-infused than in the saline-infused 
cats on d 10.  
 
Fig. 5.  
Subacute endotoxemia increases lipolysis in fat tissues. A, Relative quantities of perilipin 
mRNA in adipose tissues of LPS- and saline-infused cats. B, HSL activity in sc fat after LPS 
or saline infusion. Values are expressed as mean ± se and are relative to one cat infused with 
saline. C and D, Protein content of total and phosphorylated HSL in visceral (C) and sc (D) 
adipose tissue extracts of cats infused with LPS or saline; the graphs show the average values 
across the groups and representative Western blots. Results are normalized to β-actin. Values 
are expressed as mean ± se. E, Liver TG content (milligrams per gram liver). Individual and 
mean values are shown. *, P < 0.05 and †, P < 0.01 vs. saline-infused cats.  
Plasma HDL concentration and free and esterified cholesterol in the HDL3 subfraction were 
decreased after LPS (Table 3). Levels of HDL2 free and esterified cholesterol were slightly 
decreased in the LPS-treated cats. These data confirmed our hypothesis that LPS-induced 
lipolysis in adipose tissues increases lipid mobilization and causes not only adipose tissue 
dysfunction and dyslipidemia but also adipose and hepatic IR.  
 
 
 
Table 3.  
Concentration and composition (mean percentage weight) of plasma lipid and lipoprotein 
fractions 
 
Discussion 
The present study is the first to investigate the influence of a chronic 10-d systemic infusion 
of increasing doses of LPS on IR and on a variety of parameters for carbohydrate and lipid 
metabolism in cats.  
 
Subacute endotoxemia induces systemic inflammation in cats 
LPS infusion induced a mild increase in sc temperature, which was paralleled by a significant 
increase in circulating and tissue markers of inflammation. A 4-h infusion of LPS (2 µg/kg · 
h, iv) in cats, hence double of the highest LPS dose used in our study, has been previously 
demonstrated to induce systemic inflammation including increased temperature and plasma 
cytokines concentrations (13). In our study, the continuous infusion of increasing doses of 
LPS was sufficient to trigger a low-grade inflammatory response without seriously affecting 
the clinical conditions of the cats. Although the pyrogenic response normalized after about 5 
d of LPS infusion, levels of AGP and SAA, the two most important acute-phase proteins in 
cats (30), and MCP-1 remained markedly elevated throughout the infusion. These findings 
confirm the presence of a low-grade systemic inflammatory response that fully resembles the 
state of inflammation typical of obesity and type 2 diabetes (31).  
Of note, our study shows these effects of LPS infusion in healthy, normal-weight cats, i.e. 
independent of obesity or other underlying metabolic disturbances. In a similar experimental 
setting, a 4-wk infusion of endotoxin had been shown to increase whole-body, liver, and 
adipose depot weight to a similar extent as in high fat-fed mice (14). Similar findings were 
not observed after 10 d of endotoxemia in cats.  
 
Subacute endotoxemia enhances expression of inflammation- and immune response-
related genes, particularly in sc fat 
Chronic low-grade inflammation is recognized as a key factor in the pathogenesis of obesity-
induced IR. This low-grade inflammation is thought to be mediated by the activation of 
infiltrated neutrophils and macrophages with a subsequent increase in the expression of 
cytokines in insulin-sensitive tissues tested (3, 4). Consistent with the systemic inflammatory 
state, we found that transcripts of the chemokine IL-8 and the most potent neutrophil-specific 
serine proteinase, NEla, were increased in liver and sc fat after LPS. The number of 
neutrophils was significantly higher in liver, sc fat, and skeletal muscle and tended to be 
higher in visceral fat, confirming neutrophil migration and activation in those tissues. 
Transient infiltration of neutrophils has been shown to occur in adipose tissues of obese mice 
and to precede macrophages infiltration (32). Although macrophages could not be counted 
because of the lack of cross-reacting antibodies (17), LPS-infused cats showed a marked up-
regulation of MCP-1 in sc fat, a crucial chemokine involved in the recruitment of monocytes 
in tissues, and transcripts of the macrophage-specific antigen, F4/80, were up-regulated in 
tissues in which neutrophils were also increased; this suggests that both cell types were 
recruited in those tissues. Surprisingly, myeloperoxidase-immunostained neutrophils were not 
increased in LPS-infused cats in pancreatic islets; however, F4/80 gene expression was up-
regulated in pancreatic ILCs. Interestingly, cytokine transcripts were increased only in sc fat 
of LPS-infused cats. Desensitization of cytokine synthesis, which is well documented during 
prolonged LPS administration (33), may have occurred, despite the increasing doses of LPS 
that were given to our cats. A recent study in humans demonstrated that a low-dose acute 
endotoxemia induces adipose tissue inflammation leading to local and systemic IR (34). In 
this study, the increase in TNF-α and IL-6 mRNA levels was rapid and transient in adipose 
tissue. TNF-α transcripts returned to baseline levels 12 h after the LPS bolus. Moreover, in 
the study by Metha et al. (34), as in most of the studies conducted in humans, LPS was 
administered as a single bolus, and its effects were observed for not more than a few hours 
(60 h in the cited study).  
To our knowledge, there are no studies in humans or cats that demonstrate whether TNF-α 
mRNA expression remains increased in adipose tissue or in any other tissue after prolonged 
(a few days) continuous infusion of LPS. The fact that transcripts of TLR4, the innate 
receptor of LPS, were decreased in the skeletal muscle supports the idea that endotoxic 
desensitization had occurred, at least in some of the tested tissues (35). However, 
desensitization to the effects of LPS may not have been the same for all the inflammatory and 
metabolic parameters.  
It is noteworthy that in our animals, inguinal sc fat exhibited the strongest up-regulation of 
inflammatory genes, potentially indicating a greater sensitivity of this fat depot to LPS. In 
contrast to rodent or human models of obesity (36), an increase in fat mass in obese neutered 
cats results from a proportional increase in intraabdominal and abdominal subcutaneous fat 
(37) and increased inguinal sc fat. To our knowledge, no such studies have been performed in 
sexually intact cats. So far, it is unclear which fat depot is more critical for changes in insulin 
sensitivity in obese cats. Overall, these findings provide evidence that 10-d LPS infusion, in 
normal-weight cats, was sufficient to induce tissue-specific inflammatory responses similar to 
those associated with the metabolic endotoxemia of obesity and type 2 diabetes (1,–,5).  
 
Subacute endotoxemia induces transient IR and β-cell dysfunction 
In humans, the acute inflammatory response to infection and endotoxemia is accompanied by 
alterations of glucose metabolism, which are partly mediated by catecholamines and 
glucocorticoids (10, 11, 38,–,40). In line with the latter observation, cortisol levels transiently 
increased during LPS infusion and may possibly have contributed to the transient impairment 
of insulin sensitivity, increasing glycemia without decreasing insulin levels. In healthy 
humans, the acute administration of TNF-α is known to induce similar changes in glucose 
metabolism (41). Nevertheless, the responsiveness to insulin was normal after 10 d of LPS 
infusion, based on the whole-body insulin sensitivity index. The reason for the lack of whole-
body IR after prolonged LPS infusion is not clear. However, this is in principle consistent 
with recent findings of Cani et al. (14), who showed that 4-wk endotoxemia induced hepatic 
but not whole-body IR in mice. Because tissue-specific glucose use or tissue-specific changes 
in fat metabolism were not assessed during or after LPS infusion, we cannot exclude the 
presence of tissue-specific IR. On the other hand, the fact that insulin gene transcription was 
augmented in pancreatic LCM islets of LPS-infused cats may suggest an adaptive response of 
β-cells to a condition of increased peripheral insulin demand as, for example, occurring in 
inflammation-induced IR.  
 
Subacute endotoxemia modulates expression of insulin sensitivity-related genes in a 
tissue-specific manner in the insulin-sensitive tissues tested  
Proinflammatory cytokines and endotoxins are known to activate various kinases (1, 42, 43) 
that phosphorylate the serine/threonine of IRS-1, ultimately inhibiting insulin signaling and 
the insulin-dependent cell membrane translocation of GLUT4. In addition, cytokines increase 
the expression of SOCS family proteins, known to reduce insulin signaling by suppressing the 
tyrosine phosphorylation of IRS-1 (44). Recent publications reported increased SOCS1 and 
SOCS3 expression in insulin-sensitive tissues during obesity and endotoxemia in humans and 
mice (34, 44); this suggests that SOCS family proteins may promote IR in both conditions. 
We observed an up-regulation of SOCS3 transcripts in skeletal muscle and sc fat of the LPS-
treated cats; mRNA levels of IRS-1 were reduced in skeletal muscle; similarly to obese 
humans and cats (2, 45), gene and protein expression of GLUT4 was decreased in visceral fat. 
In addition, the gene and protein expression of the nuclear receptors PPARγ1 and -2, key 
transcriptional regulators preserving insulin sensitivity and reducing cytokine expression (46), 
were decreased in the liver of LPS-treated cats. In our study, we extend previous findings in 
mice (14) by demonstrating that although whole-body insulin sensitivity was not changed at d 
10 of LPS infusion, the expression of important genes that preserve insulin sensitivity was 
reduced by LPS in major insulin-responsive tissues (liver, skeletal muscle, and visceral and sc 
adipose tissue) and that the degree of the response to LPS varied with respect to the tissue and 
to the target.  
 
Subacute endotoxemia alters lipid and lipoprotein metabolism in cats 
Among the target tissues of insulin, adipose tissue has a predominant role in the development 
of IR and disorders of glucose and lipid metabolism in human obesity. Adipose tissue IR in 
obesity is linked to the inflammation-mediated impairment of insulin action in respect to 
lipolysis and glucose uptake. Under physiological conditions, it has been shown that visceral 
adipose tissue has higher basal lipolysis activity than sc fat in rats (47). Similarly, HSL 
activity was significantly higher in visceral (1.3 ± 0.1) than in sc adipose tissue (0.7 ± 0.17; P 
< 0.01) of our saline-infused cats (data not shown). During infections and obesity, increased 
cytokines and endotoxin levels activate lipolysis in adipose tissues through protein kinase A-
mediated phosphorylation of the lipolytic enzyme HSL and perilipin, a protein associated 
with the cytoplasmatic lipid droplet (48). As a result, instead of being oxidized, mobilized 
fatty acids are reesterified into TGs in the liver (49) and are likely to cause IR through the 
activation of kinases involved in the serine/threonine phosphorylation of IRS-1 in this tissue 
(50). Furthermore, the lipolytic state and the biological characteristics of visceral and sc 
depots may change under inflammatory conditions.  
In fact, after the LPS treatment, HSL activity and protein expression increased significantly in 
sc fat, whereas in visceral fat the increase in HSL activity did not reach statistical 
significance. In the present study, 10 d endotoxemia activated lipolysis as demonstrated by 
the increased activity and protein expression of HSL (in particular in sc fat) and decreased 
mRNA expression of perilipin; both may have led to the significantly reduced size of 
adipocytes in visceral and sc fat. In agreement, recent data showed that 4 wk LPS treatment 
increased the number of sc adipocytes of smaller size in LPS-infused mice (14). Moreover, an 
increased proportion of small adipose cells in sc adipose tissue has been associated with 
inflammation and IR independently of obesity (51).  
In LPS-infused cats, serum TGs were increased initially, although the increase was followed 
by a rapid decline to preinfusion levels. Nonetheless, the TG content of the liver was 
significantly increased at d 10. These data support the notion that, in response to LPS, fatty 
acid oxidation decreases, whereas TG synthesis increases in the liver. Decreased fatty acid 
oxidation in response to LPS is consistent with the reduced expression of PPARγ in the liver 
because PPARγ has been shown to trigger the expression of proteins involved in fatty acid 
oxidation, whereas decreased hepatic PPARγ transcription contributes to reduce fatty acid 
oxidation (52, 53). These findings suggest that the infusion of LPS in normal-weight cats was 
sufficient to impair the antilipolytic action of insulin in adipose tissue and to induce hepatic 
steatosis, both considered obesity-related manifestations of adipose and hepatic IR (54).  
Acute infection and inflammation are associated with plasma lipid and lipoprotein profiles, 
which resemble those observed in the human metabolic syndrome (55). Cats share a 
lipoprotein profile that is qualitatively similar to that in humans; this is, for example, reflected 
by the presence of separable HDL fractions and similar dyslipidemic changes in obesity (56). 
LPS-infused cats had decreased total plasma cholesterol, HDL, and HDL-cholesterol, which 
is similar to humans with endotoxemia (55, 57). In humans with sepsis or the metabolic 
syndrome, low levels of HDL cholesterol and elevated levels of acute-phase proteins have 
been identified as independent risk factors for the future development of IR and type 2 
diabetes (58). The mechanism by which inflammation decreases total and HDL cholesterol 
levels is not completely understood. Similar findings have been reported in nonhuman 
primates and humans, whereas in rodents cholesterol levels increased during the acute-phase 
response.  
Interestingly, it has been shown that lipoprotein composition changes with infection. Acute-
phase HDL contains less esterified cholesterol and apolipoprotein A-I, with the latter being 
partly replaced by apolipoprotein containing the inflammatory protein SAA (apolipoprotein 
SAA). The presence of SAA in HDL was suggested to increase HDL clearance and decrease 
the ability of HDL to inhibit LDL oxidation (58, 59). The protective capacity of HDL, 
especially of the HDL3 fraction, is also diminished in metabolic syndrome patients (59). In 
LPS-infused cats, the HDL3 and HDL2 fractions contained less free and esterified cholesterol. 
Because HDL, besides its antioxidant effects, has antiinflammatory properties including the 
down-regulation of cytokines and the synthesis of adhesion molecules (58), the decreased and 
modified composition of HDL may have contributed to amplifying the inflammatory reaction 
in LPS-infused cats.  
In conclusion, we confirmed, to some extent, previous findings from Cani et al. (14) and 
showed that despite normal whole-body insulin sensitivity, the local and systemic 
inflammation induced by prolonged LPS infusion resulted in tissue-specific IR. Our study 
provided further important insight into the tissue-specific modulation of glucose and insulin 
metabolism-related targets. In addition, we provided new evidence that LPS-induced adipose 
tissue inflammation, in particular in the sc depot, induced severe alterations in lipid 
metabolism, which included the disruption of TG storage and the increase in lipolysis; this in 
turn led to the development of dyslipidemia and hepatic steatosis in normal-weight cats. 
Whether a more prolonged endotoxemia may permanently impair adipose function and lipid 
and lipoprotein metabolism and may therefore contribute to the development of systemic IR 
to a similar extent as in obese cats requires further investigation. Additional studies of the 
biological processes and the molecular mechanisms that underlie tissue-specific development 
of inflammation and the related metabolic alterations in cats may allow the development of 
more targeted therapeutic approaches to managing IR in infection, obesity, and type 2 
diabetes. LPS infusion in cats thus provides a promising model to study the cross talk 
between metabolic and inflammatory responses in the development of adipose tissue 
dysfunction and IR in the absence of obesity.  
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